Close menu
Feb 18
2021
Available online WHITE PAPER : A GAME-CHANGING PRECLINICAL TESTING MODEL FOR SYNERGISTIC IMMUNO-ONCOLOGY DRUG CANDIDATES
A standardized in vivo plateform: in ovo human tumor xenografts This white paper reviews the current benefits of immuno-oncology therapeutic strategies over conventional treatments and highlights the main difficulty facing drug developers today: the high combinatorial […]
Feb 16
Register for free Fast and cost-effective solutions for in vivo anticancer drug evaluation, using the chicken embryo model
Wed, Mar 24, 2021 | 4:00 PM GMT Xavier Rousset, PhD, R&D Team Leader Sponsored by INOVOTION Preclinical oncology assays using classical models such as the mouse suffer from several limitations which significantly hamper overall […]
Jan 19
INOVOTION WILL ATTEND THE PREDICT : TUMOR MODELS FOR IMMUNO-ONCOLOGY SUMMIT
Equip Your Preclinical I/O Studies with Robust Models to Enable Enhanced Clinical Relevancy & Translatability As the only industry-focused meeting dedicated to preclinical scientists and translational oncologists in the immunotherapy space, the PREDiCT Series […]
contact@inovotion.com
France : +33 (0)476 549 512 USA : +1 (617) 230-6738